Skip to content

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05299229
Enrollment
12
Registered
2022-03-28
Start date
2020-12-29
Completion date
2021-12-31
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Eclampsia

Brief summary

The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, Edwards Life Sciences) - compared to hemodynamic assessments by intermittent echocardiography in early onset preeclampsia.

Interventions

DIAGNOSTIC_TESTEchocardiogrpahy and non-invasive monitoring

Study participants will have echocardiography and non-invasive monitoring by chest/back sensors and a finger cuff.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BP \>160 or DBP \>110 * gestational age between 20-34 weeks * singleton pregnancy

Exclusion criteria

* prior diagnosis of chronic hypertension or hypertensive disorder of pregnancy * multi-fetal pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in cardiac output (L/min) as measured by NICOM (bioreactance) monitoringBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Cardiac output (L/min) ranges 3-10 L/min, lower values associated with more severe preeclampsia
Change in systemic vascular resistance (dynes/sec*cm-5) as measured by NICOM (bioreactance) monitoringBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Systemic vascular resistance ranges 600-2000 dynes/sec\*cm-5, higher values associated with more severe preeclampsia
Change in Cardiac output (L/min) as measured by Clearsite (pulse wave analysis) monitoringBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Cardiac output (L/min) ranges 3-10 L/min, lower values associated with more severe preeclampsia
Change in Systemic vascular resistance (dynes/sec*cm-5) as measured by Clearsite (pulse wave analysis) monitoringBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Systemic vascular resistance ranges 600-2000 dynes/sec\*cm-5, higher values associated with more severe preeclampsiaanalysis) monitoring
Change in Cardiac output (L/min) as measured by transthoracic echocardiographyBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Cardiac output (L/min) ranges 3-10 L/min, lower values associated with more severe preeclampsia
Change in Systemic vascular resistance (dynes/sec*cm-5) as measured by transthoracic echocardiographyBaseline (typically 3-5 days before birth, but can be up to 5 weeks before birth), 3 days after birth (postpartum)Systemic vascular resistance ranges 600-2000 dynes/sec\*cm-5, higher values associated with more severe preeclampsia

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026